Media Center


FDA Concern Over Experimental Uses of Balloon Angioplasty

By Burg Simpson

On March 8, 2017 the U.S. Food and Drug Administration (FDA) issued a safety communication, alerting health care providers and patients considering treatment options for conditions causing autonomic dysfunction (such as Parkinson’s disease, multiple sclerosis, fibromyalgia, multiple system atrophy, postural tachycardia syndrome peripheral neuropathies, primary dysautonomia, and familial dysautonomia), of the risks associated with the… Read more »

Top 100 National Trial Lawyers Legal 500 Best Lawyers in America Super Lawyers US News 2014 Top 25 Most Influential Lawyers